Raffin Thomas A. — SEC Form 4 filings

SEC reporting owner CIK 1512119. 4 Form 4 filings on record with FilingPulse; latest filed 2025-07-10.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-06-05 to 2025-07-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
LUMOS PHARMA, INC.Director29
Akoya Biosciences, Inc. (AKYA)Director28

Form 4 filings — Raffin Thomas A.

FiledFormIssuerReported transactionsSource
2025-07-104Akoya Biosciences, Inc. (AKYA)Other (J): 234,592 · Other (J): 1,737,712 · Other (J): 15,937,535 · Other (J): 16,860 (derivative) @ $0 · Other (J): 30,549 (derivative) @ $0 · Other (J): 56,322 (derivative) @ $0 · +1 moreEDGAR
2024-12-134LUMOS PHARMA, INC.Disposition to issuer (D): 9,406 · Disposition to issuer (D): 3,345 (derivative) · Disposition to issuer (D): 3,328 (derivative) · Disposition to issuer (D): 5,684 (derivative) · Disposition to issuer (D): 3,431 (derivative) · Disposition to issuer (D): 2,910 (derivative) · +2 moreEDGAR
2024-06-074LUMOS PHARMA, INC.Grant/award (A): 3,328 (derivative) @ $0EDGAR
2024-06-054Akoya Biosciences, Inc. (AKYA)Grant/award (A): 50,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1512119 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →